Proline bis-amides as potent dual orexin receptor antagonists

被引：63

作者：

Bergman, Jeffrey M. ^{[1
]}

Roecker, Anthony J. ^{[1
]}

Mercer, Swati P. ^{[1
]}

Bednar, Rodney A. ^{[1
]}

Reiss, Duane R. ^{[2
]}

Ransom, Richard W. ^{[2
]}

Harrell, C. Meacham ^{[2
]}

Pettibone, Douglas J. ^{[2
]}

Lemaire, Wei ^{[2
]}

Murphy, Kathy L. ^{[2
]}

Li, Chunze ^{[3
]}

Prueksaritanont, Thomayant ^{[3
]}

Winrow, Christopher J. ^{[2
]}

Renger, John J. ^{[2
]}

Koblan, Kenneth S. ^{[2
]}

Hartman, George D. ^{[1
]}

Coleman, Paul J. ^{[1
]}

机构：

[1] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA

[2] Merck Res Labs, Dept Depress & Circadian Disorders, West Point, PA 19486 USA

[3] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 04期

关键词：

D O I：

10.1016/j.bmcl.2008.01.001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of OX2R/OX1R dual orexin antagonists was prepared based on a proline bis-amide identified as a screening lead. Through a combination of classical and library synthesis, potency enhancing replacements for both amide portions were discovered. N-methylation of the benzimidazole moiety within the lead structure significantly reduced P-gp susceptibility while increasing potency, giving rise to good brain penetration. A compound from this series has demonstrated in vivo central activity when dosed peripherally in a pharmacodynamic model of orexin activity. Published by Elsevier Ltd.

引用

页码：1425 / 1430

页数：6

共 50 条

[21] Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease
S. M. Ragsdale
J. M. Radovich
I. I. Coiduras
W. V. McCall
S. C. Grant
C. Lee
A. Wilber
npj Biological Timing and Sleep, 2 (1):
[22] An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Janto, Kayla
Prichard, J. Roxanne
Pusalavidyasagar, Snigdha
JOURNAL OF CLINICAL SLEEP MEDICINE, 2018, 14 (08): : 1399 - 1408
[23] Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation
Ajna Hamidovic
CNS Drugs, 2022, 36 : 411 - 417
[24] Orexin Receptor Antagonists and Insomnia
Xin Wu
Tao Xue
Zhouqing Chen
Zhong Wang
Gang Chen
Current Psychiatry Reports, 2022, 24 : 509 - 521
[25] Selective orexin receptor antagonists
Lebold, Terry P.
Bonaventure, Pascal
Shireman, Brock T.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4761 - 4769
[26] Orexin Receptor Antagonists and Insomnia
Wu, Xin
Xue, Tao
Chen, Zhouqing
Wang, Zhong
Chen, Gang
CURRENT PSYCHIATRY REPORTS, 2022, 24 (10) : 509 - 521
[27] Bis-amides and amine bis-amides as ligands for olefin polymerization catalysts based on V(IV), Cr(IV) and Mn(IV): A density functional theory (DFT) study.
Firman, TK
Ziegler, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U315 - U315
[28] SEPARATION OF THE STEREOISOMERS OF A HOMOLOGOUS SERIES OF BIS-AMIDES ON CHIRAL STATIONARY PHASES
PIRKLE, WH
POCHAPSKY, TC
CHROMATOGRAPHIA, 1988, 25 (07) : 652 - 654
[29] Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)
Behnke, Dirk
Cotesta, Simona
Hintermann, Samuel
Fendt, Markus
Gee, Christine E.
Jacobson, Laura H.
Laue, Grit
Meyer, Arndt
Wagner, Trixie
Badiger, Sangamesh
Chaudhari, Vinod
Chebrolu, Murali
Pandit, Chetan
Hoyer, Daniel
Betschart, Claudia
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (23) : 5555 - 5560
[30] Orexin, orexin receptor antagonists and central cardiovascular control
Carrive, Pascal
FRONTIERS IN NEUROSCIENCE, 2013, 7

← 1 2 3 4 5 →